Serum Procollagen Type I N-Terminal Propeptide and Osteocalcin Levels in Korean Children and Adolescents

被引:24
|
作者
Choi, Ji-Seon [1 ]
Park, Ikchun [1 ]
Lee, Soo Jung [2 ]
Ju, Hyo Jin [3 ]
Lee, Hyeyoung [1 ]
Kim, Jayoung [1 ]
机构
[1] Catholic Kwandong Univ, Int St Marys Hosp, Dept Lab Med, Coll Med, 25 Simgok Ro 100Beon-gil, Incheon 22711, South Korea
[2] Catholic Kwandong Univ, Int St Marys Hosp, Dept Pediat, Coll Med, Incheon, South Korea
[3] Catholic Kwandong Univ, Dept Med Humanities, Coll Med, Incheon, South Korea
关键词
Children; adolescent; P1NP; osteocalcin; bone marker; BONE TURNOVER MARKERS; REFERENCE INTERVALS; BIOCHEMICAL MARKERS; COLLAGEN; ASSAY;
D O I
10.3349/ymj.2019.60.12.1174
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Bone markers can be useful for the diagnosis and treatment of skeletal diseases in children and adolescents. Owing to high skeletal growth velocity and rapid bone turnover, children and adolescents have higher bone marker levels than adults. Thus, a valid age- and sex-specific reference should be established for pediatric populations living in similar environments. We aimed to assess the associations of procollagen type I N-terminal propeptide (P1NP) and osteocalcin with age and sex in a group of healthy Korean children and adolescents. Materials and Methods: The participants (290 boys and 290 girls, age range 0-18 years) were Korean outpatients. Serum P1NP and osteocalcin levels were measured in control materials and patient samples by electrochemiluminescence immunoassay using an automated Cobas e411 analyzer. Results: Significant age-dependent variations in bone marker levels were observed in both sexes (p<0.001). 'the highest P1NP levels were observed during the first year of life; thereafter, levels decreased. until puberty. There was no postnatal peak for osteocalcin; however, its levels remained higher than the adult reference range throughout childhood. Significant differences were observed between boys and girls (p<0.05), especially between the ages of 12 and 17 years. Cobas e411 results for P1NP showed satisfactory precision and linearity. Conclusion: We established reference data for P1NP and osteocalcin levels in healthy Korean children and adolescents, as the first and only study of these parameters in pm-adulthood in Korea. Cobas e411-quantified bone markers may be useful for determining bone metabolism indices.
引用
收藏
页码:1174 / 1180
页数:7
相关论文
共 50 条
  • [1] Reference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly Chinese men
    Shou, Zhangxuan
    Jin, Xue
    Bian, Pingda
    Li, Xiuyang
    Chen, Jinping
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2017, 17 (05) : 773 - 778
  • [2] Changes in Collagen Type I C-Telopeptide and Procollagen Type I N-Terminal Propeptide During the Menopause Transition
    Shieh, Albert
    Karlamangla, Arun S.
    Gossiel, Fatma
    Eastell, Richard
    Greendale, Gail A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (06) : 1580 - 1589
  • [3] Serum levels of osteocalcin and type I procollagen in children with celiac disease
    Pratico, G
    Caltabiano, L
    Bottaro, G
    Palano, GM
    Rotolo, N
    Spina, M
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1997, 24 (02) : 170 - 173
  • [4] Validation of an automated intact N-terminal propeptide of type I procollagen (PINP) assay
    Koivula, Marja-Kaisa
    Richardson, Jill
    Leino, Aila
    Valleala, Heikki
    Griffiths, Katie
    Barnes, Alex
    Konttinen, Yrjo T.
    Garrity, Martha
    Risteli, Juha
    CLINICAL BIOCHEMISTRY, 2010, 43 (18) : 1453 - 1457
  • [5] The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure
    Takao Tsuchida
    Eiji Ishimura
    Takami Miki
    Naoki Matsumoto
    Hiroshi Naka
    Shuichi Jono
    Masaaki Inaba
    Yoshiki Nishizawa
    Osteoporosis International, 2005, 16 : 172 - 179
  • [6] The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure
    Tsuchida, T
    Ishimura, E
    Miki, T
    Matsumoto, N
    Naka, H
    Jono, S
    Inaba, M
    Nishizawa, Y
    OSTEOPOROSIS INTERNATIONAL, 2005, 16 (02) : 172 - 179
  • [7] Effects of raloxifene and alendronate on bone turnover as assessed by procollagen type I N-terminal propeptide
    Eastell, R.
    Rogers, A.
    Ni, X.
    Krege, J. H.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 (06) : 1927 - 1934
  • [8] A multicenter study to evaluate harmonization of assays for N-terminal propeptide of type I procollagen (PINP): a report from the IFCC-IOF Joint Committee for Bone Metabolism
    Cavalier, Etienne
    Eastell, Richard
    Jorgensen, Niklas Rye
    Makris, Konstantinos
    Tournis, Symeon
    Vasikaran, Samuel
    Kanis, John A.
    Cooper, Cyrus
    Pottel, Hans
    Morris, Howard A.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2019, 57 (10) : 1546 - 1555
  • [9] Value of procollagen type I N-terminal propeptide (P1NP) as a bone formation marker
    Oremek, G. M.
    Holzgreve, F.
    Maurer-Grubinger, C.
    Diaremes, P.
    Erbe, C.
    Ohlendorf, D.
    ZENTRALBLATT FUR ARBEITSMEDIZIN ARBEITSSCHUTZ UND ERGONOMIE, 2024, 74 (01): : 43 - 48
  • [10] Reference values of osteocalcin and procollagen type I N-propeptide plasma levels in a healthy Central European population aged 0-18 years
    Bayer, M.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 (02) : 729 - 736